Results 231 to 240 of about 303,632 (262)

Polycythemia (Excluding Polycythemia Vera)

2020
openaire   +1 more source

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

New England Journal of Medicine, 2004
Raffaele Landolfi, Roberto Marchioli, Heinz Gisslinger   +2 more
exaly  

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Roberto Marchioli, Giorgina Specchia, Valerio De Stefano   +2 more
exaly  

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Leukemia, 2017
F. Passamonti, T. Giorgino, B. Mora, P. Guglielmelli, E. Rumi, M. Maffioli, A. Rambaldi, M. Caramella, R. Komrokji, J. Gotlib, J. Kiladjian, F. Cervantes, T. Devos, F. Palandri, V. Stefano, M. Ruggeri, R. Silver, G. Benevolo, F. Albano, D. Caramazza, M. Merli, D. Pietra, R. Casalone, G. Rotunno, T. Barbui, M. Cazzola, A. Vannucchi   +26 more
semanticscholar   +1 more source

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

New England Journal of Medicine, 2015
Alessandro Maria Vannucchi, Martin Griesshammer, Tamás Masszi   +2 more
exaly  

[Polycythemia vera I].

Deutsche medizinische Wochenschrift (1946), 1998
G, STECHER, H, WOLFERS, P, NETTESHEIM
openaire   +2 more sources

POLYCYTHEMIA VERA.

JAMA: The Journal of the American Medical Association, 1906
openaire   +1 more source

Two Clinical Phenotypes in Polycythemia Vera

New England Journal of Medicine, 2014
Jerry L Spivak, Alison R Moliterno
exaly  

Polycythemia Vera and Other Polycythemia Syndromes

2007
openaire   +2 more sources

Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera

New England Journal of Medicine, 1998
Alison R Moliterno, Jerry L Spivak
exaly